22
Views
2
CrossRef citations to date
0
Altmetric
Review

Acute idiopathic pericarditis: current immunological theories

, , , , &
Pages 49-55 | Published online: 27 Sep 2012

References

  • Launbjerg J, Fruergaard P, Hesse B, Jørgensen F, Elsborg L, Petri A. Long-term risk of death, cardiac events and recurrent chest pain in patients with acute chest pain of different origin. Cardiology. 1996;87(1):60–66.
  • Imazio M, Bobbio M, Cecchi E, et al. Colchicine as first-choice therapy for recurrent pericarditis: results ofthe CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005;165(17):1987–1991.
  • Spodick DH. Acute pericarditis: current concepts and practice. JAMA. 2003;289(9):1150–1153.
  • Shabetai R. Recurrent pericarditis: recent advances and remaining questions. Circulation. 2005;112(13):1921–1923.
  • Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. Relapsing pericarditis. Heart. 2004;90(11):1364–1368.
  • Maisch B, Seferović PM, Ristić AD, et al; for Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004;25(7):587–610.
  • Fowler NO. Recurrent pericarditis. Cardiol Clin. 1990;8(4):621–626.
  • Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112(13):2012–2016.
  • Brucato A, Brambilla G, Adler Y, Spodick DH, Canesi B. Therapy of recurrent acute pericarditis: a rheumatological solution? Clin Exp Rheumatol. 2006;24(1):45–50.
  • Brucato A, Brambilla G, Moreo A, et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol. 2006;98(2):267–271.
  • Imazio M, Brucato A, Trinchero R, Adler Y Diagnosis and management of pericardial disease. Nat Rev Cardiol. 2009;6(12):743–751.
  • Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial disease. Circulation. 2010; 121(7):916–928.
  • Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011;123(10):1092–1097.
  • Simon C, Dieli M, Brucato A, et al. Images in cardiovascular medicine. Bacterial pericarditis due to Providencia stuartii: an atypical case of relapsing pericarditis. Circulation. 2010;122(4):e401–s403.
  • Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115(21):2739–2744.
  • Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today. 1993;14(9):426–430.
  • Pankuweit S, Wädlich A, Meyer E, Portig I, Hufnagel G, Maisch B. Cytokine activation in pericardial fluids in different forms of pericarditis. Herz. 2000;25(8):748–754.
  • Imazio M, Brucato A, Doria A, et al. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. Int J Cardiol. 2009;136(3):289–293.
  • Caforio AL, Brucato A, Doria A, et al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010;96(10):779–784.
  • Caforio AL, Bonifacio E, Stewart JT, et al. Novel organ-specific cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol. 1990;15(7):1527–1534.
  • Caforio AL, Keeling PJ, Zachara E, et al. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet. 1994; 344(8925):773–777.
  • Caforio ALP, Mahon NG, Baig KM, et al. Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation. 2007;115(1):76–83.
  • Caforio ALP, Calabrese F, Angelini A, et al. A prospective study ofbiopsy- proven myocarditis: prognostic relevance of clinical and etiopathoge- netic features at diagnosis. Eur Heart J. 2007;28(11):1326–1333.
  • Imazio M, Demichelis B, Cecchi E, et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol. 2003;42(12):2144–2148.
  • Richardson P, McKenna WJ, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93(5):841–842.
  • Maisch B, Berg PA, Kocksiek K. Clinical significance of immunopatho- logical findings in patients with post-pericardiotomy sindrome. I relevance of antibody pattern. Clin Exp Immunol. 1979;38(2):189–197.
  • Kaplan MH, Frengley JD. Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomy and postinfarction syndromes and cardiomyopathies. Am J Cardiol 1969;24(4):459–473.
  • Caforio AL, Grazzini M, Mann JM, et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation. 1992;85(5):1734–1742.
  • Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol. 1993;22(5):1378–1384.
  • Lauer B, Schannwell M, Kühl U, Strauer BE, Schultheiss HP. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol. 2000;35(1):11–18.
  • Perriard JC, Hirschy A, Ehler E. Dilated cardiomyopathy: a disease of the intercalated disc? Trends Cardiovasc Med. 2003;13(1):30–38.
  • Rigante D. Autoinflammatory syndromes behind the scenes of recurrent fevers in children. Med Sci Monit. 2009;15(8):RA179-RA187.
  • Cantarini L, Lucherini OM, Baldari CT, Laghi Pasini F, Galeazzi M. Familial clustering of recurrent pericarditis may disclose tumor necrosis factor receptor associated periodic syndrome. Clin Exp Rheumatol. 2010;28(3):405–407.
  • Brucato A, Brambilla G. Recurrent idiopathic pericarditis: familial occurrence. Int J Cardiol. 2005;102(3):529.
  • Maggiolini S, Tiberti G, Cantarini L, et al. Large pericardial effusion in a family with recurrent pericarditis: A report of probable x-linked transmission. Exp Clin Cardiol. 2011;16(2):54–56.
  • Rigante D, Cantarini L, Imazio M, et al. Autoinflammatory diseases and cardiovascular manifestations. Ann Med. 2011;43(5):341–346.
  • Okutur K, Seber S, Oztekin E, Bes C, Borlu F Recurrent pericarditis as the initial manifestation of Familial Mediterranean fever. Med Sci Monit. 2008;14(12):CS139-CS141.
  • Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997;90(4):797–807.
  • Brucato A, Shinar Y, Brambilla G, et al. Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients. Lupus. 2005;14(9):670–674.
  • McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97(1):133–144.
  • Dodé C, André M, Bienvenu T, et al; for French Hereditary Recurrent Inflammatory Disorder Study Group. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2002;46(8):2181–2188.
  • McDermott EM, Smillie DM, Powell RJ. Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. Mayo Clin Proc. 1997;72(9):806–817.
  • Cantarini L, Lucherini OM, Brucato A, et al. Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol. 2012;101(7):525–531.
  • Spodick DH. The Pericardium: A Comprehensive Textbook. New York, NY: Marcel Dekker; 1997.
  • Imazio M, Brucato A, Trinchero R, Spodick D, Adler Y. Individualized therapy for pericarditis. Expert Rev Cardiovasc Ther. 2009;7(8): 965–975.
  • Imazio M, Brucato A, Cemin R, et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 2011;155(7):409–414.
  • Marcolongo R, Russo R, Laveder F, Noventa F, Agostini C. Immunosuppressive therapy prevents recurrent pericarditis. J Am Coll Cardiol 1995;26(5):1276–1279.
  • Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118(6):667–671.
  • Vianello F, Cinetto F, Cavraro M, et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol. 2011 ;147(3): 477–478.
  • Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–1812.
  • Imazio M, Trinchero R, Brucato A, et al. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31(22): 2749–2754.
  • Picco P, Brisca G, Traverso F, Loy A, Gattorno M, Martini A. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum. 2009;60(1):264–268.